3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
6
Observational
1
Expanded_access
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
2
Sexual Dysfunction, Physiological
1
PROMs
1
Neoplasms
1
Locally Advanced Melanoma
1
Eunuchism
1
Erectile Dysfunction
1
Cutaneous Squamous Cell Carcinoma (CSCC)
1
Carcinoma, Basal Cell
1
Advanced Non-small Cell Lung Cancer
1
Interventions
sonidegib
3
Tomography, Optical Coherence
3
Mohs Surgery
3
HhAntag691
3
Imiquimod
2
Blood Specimen Collection
2
teriflunomide
1
cemiplimab
1
Watchful Waiting
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Spectrum Analysis, Raman
1
Predictive Learning Models
1
Patient Reported Outcome Measures
1
Natalizumab
1
Microscopy, Confocal
1
Microarray Analysis
1
Intravital Microscopy
1
Immunotherapy
1
Fingolimod Hydrochloride
1
Dimethyl Fumarate
1
Dermoscopy
1
Biopsy
1
Alemtuzumab
1
Aftercare
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Carcinoma, Basal Cell
×
cemiplimab
×
Clear all
NCT03836105
2025-10-15
CASE
Regeneron Pharmaceuticals
Completed
287 enrolled